Advertisement
UK markets close in 25 minutes

  • FTSE 100

    7,814.75
    -150.78 (-1.89%)
     

  • FTSE 250

    19,365.24
    -333.65 (-1.69%)
     

  • AIM

    739.58
    -10.70 (-1.43%)
     

  • GBP/EUR

    1.1701
    -0.0009 (-0.08%)
     

  • GBP/USD

    1.2445
    -0.0001 (-0.01%)
     

  • Bitcoin GBP

    49,904.63
    -1,669.30 (-3.24%)
     

  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     

  • S&P 500

    5,050.28
    -11.54 (-0.23%)
     

  • DOW

    37,808.03
    +72.92 (+0.19%)
     

  • CRUDE OIL

    85.64
    +0.23 (+0.27%)
     

  • GOLD FUTURES

    2,397.80
    +14.80 (+0.62%)
     

  • NIKKEI 225

    38,471.20
    -761.60 (-1.94%)
     

  • HANG SENG

    16,248.97
    -351.49 (-2.12%)
     

  • DAX

    17,736.51
    -290.07 (-1.61%)
     

  • CAC 40

    7,916.37
    -128.74 (-1.60%)
     
Money:

How to avoid tax creep in retirement

The state pension went up 8.5% in April, but frozen thresholds mean pensioners will be paying more tax

Portfolio Update

Oxford Technology 4 VCT plc

The Board notes the announcement made yesterday by Arecor Therapeutics plc ("Arecor"), one of the Company's investee companies, to seek to have its shares admitted to trading on AIM, RNS No: 6941Y.

Assuming the placing and admission takes place at a share price in the range indicated, the Company's value of its investment in Arecor is anticipated to increase. The Board intends to make a further announcement that will quantify that impact, after the admission has taken place.

For further information contact:

Oxford Technology Management

Lucius Cary

01865 784466